4:01 AM
 | 
Sep 26, 2018
 |  BC Extra  |  Financial News

Perceptive leads Lyra’s $29.5M series B

Editor's Note: This article was updated on Sep 26, 2018 at 11:42 AM PDT

Ears, nose and throat disease company Lyra Therapeutics Inc. (Watertown, Mass.) raised $29.5 million in a series B round led by Perceptive Advisors. Fellow new investors RA Capital, ArrowMark Partners and Soleus Capital also participated, as did existing investors Polaris Venture Partners, North Bridge Venture Partners...

Read the full 206 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >